Data / Research funding / Stem Cell Research - Induced Pluripotent Stem Cell - Non-Human
Stem Cell Research - Induced Pluripotent Stem Cell - Non-Human: 176 NIH awards ($118.5M) to 101 organizations
176 NIH awards ($118.5M) in the NIH spending category Stem Cell Research - Induced Pluripotent Stem Cell - Non-Human, to 101 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
176 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Enhancer-based Immune and Beta Cell Dysregulation Underlying T1D Risk | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $3,303,112 | September 15, 2020 | June 30, 2025 | SUH, YOUSIN | reporter.nih.gov |
| Retinal Ganglion Cell Replacement in Clinically Relevant Models of Optic Neuropathy | NIH | National Eye Institute | 2021 to 2022 | $3,026,491 | September 30, 2018 | August 31, 2024 | REX, TONIA S | reporter.nih.gov |
| Impact of peripheral nerves on mesenchymal cell fate in extremity trauma | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $2,991,689 | August 1, 2017 | April 30, 2026 | LEVI, BENJAMIN | reporter.nih.gov |
| Defining Genetic Architecture and Pathways of DCM | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,976,096 | April 1, 2005 | January 31, 2026 | SEIDMAN, JONATHAN G | reporter.nih.gov |
| Retinal disease models for translational photoreceptor replacement | NIH | National Eye Institute | 2021 to 2022 | $2,898,123 | September 30, 2018 | May 31, 2025 | WOLFE, JOHN H | reporter.nih.gov |
| Developing Cone-Dominant Retinal Disease Models as a Resource for Translational Vision Research | NIH | National Eye Institute | 2021 to 2022 | $2,820,106 | September 30, 2018 | August 31, 2022 | CARROLL, JOSEPH | reporter.nih.gov |
| Three-dimensional conformation changes associated with T cell memory and autoimmunity | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,550,277 | September 15, 2020 | June 30, 2025 | HAWKINS, RAYMOND DAVID | reporter.nih.gov |
| Prenatal Origins of Neurometabolic Consequences | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,517,422 | September 1, 2021 | July 31, 2026 | DEVASKAR, SHERIN U | reporter.nih.gov |
| Targeting the genotype to phenotype link in HCM as a therapeutic strategy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,339,175 | March 1, 2021 | February 28, 2026 | MERCOLA, MARK | reporter.nih.gov |
| Developmental Origin, Injury and Epigenomic Regulation of NF1-Associated Peripheral Nerve Sheath Tumors | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,339,120 | April 15, 2021 | June 30, 2024 | ZHU, YUAN | reporter.nih.gov |
| Novel roles for p27 as transcriptional co-regulator of cJun in stem cells and development | NIH | National Cancer Institute | 2021 to 2024 | $2,319,039 | September 1, 2020 | August 31, 2025 | SLINGERLAND, JOYCE MARIE | reporter.nih.gov |
| Toward Understanding the Role of the Polycomb Complex in Skin Control | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $2,130,652 | February 1, 2016 | August 31, 2025 | EZHKOVA, ELENA | reporter.nih.gov |
| Genetic Analysis of MicroRNA Functions in Skin Stem Cells In Vivo | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $2,013,300 | July 1, 2014 | November 30, 2025 | YI, RUI | reporter.nih.gov |
| Derivation of Functional Spermatogonia Stem Cells from Rhesus Macaque iPSCs | NIH | Office of the Director, National Institutes of Health | 2021 to 2022 | $1,921,633 | September 9, 2019 | June 30, 2024 | EASLEY, CHARLES A. | reporter.nih.gov |
| CGG repeat associated translation in Fragile X-associated Tremor/Ataxia Syndrome | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,869,734 | April 1, 2014 | December 31, 2025 | TODD, PETER K | reporter.nih.gov |
| Towards a preclinical model for overcoming infertility with induced pluripotent stem cells | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $1,802,832 | June 1, 2019 | May 31, 2025 | CLARK, AMANDER | reporter.nih.gov |
| Modeling Frontotemporal Dementia in Rhesus Macaques | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2024 | $1,789,771 | September 30, 2019 | May 31, 2026 | EMBORG, MARINA | reporter.nih.gov |
| Therapeutic Development of Osteogenic Oxysterol, Oxy133, for Spine Fusion | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $1,707,540 | September 1, 2021 | August 31, 2024 | PARHAMI, FARHAD | reporter.nih.gov |
| Nucleus Accumbens-Associated Protein-1 in Melanoma Immunotherapy | NIH | National Cancer Institute | 2021 to 2023 | $1,663,168 | July 3, 2018 | November 30, 2024 | YANG, JIN-MING | reporter.nih.gov |
| Identification of Genetic and Molecular Bases of Derived Phenotypes in Primate Brain Development | NIH | National Human Genome Research Institute | 2021 to 2023 | $1,574,253 | May 16, 2023 | June 30, 2024 | SESTAN, NENAD | reporter.nih.gov |
| Biodistribution and PK modeling of rat vs. human systems | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $1,543,653 | September 11, 2020 | February 28, 2025 | SHULER, MICHAEL L | reporter.nih.gov |
| Leveraging Human iPSC-derived beta-cells to Probe Antigen Specificity of Anti-islet Memory T Cells in T1D | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2024 | $1,503,173 | February 1, 2023 | July 31, 2025 | TEYTON, LUC | reporter.nih.gov |
| Investigating mechanisms of vertebrate myoblast fusion using zebrafish as a model | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $1,417,766 | August 1, 2020 | May 31, 2025 | CHEN, ELIZABETH H | reporter.nih.gov |
| DNA repair pathway choice mediates somatic cell reprogramming | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,401,318 | September 1, 2020 | May 31, 2025 | EGLI, DIETER MEINRAD | reporter.nih.gov |
| Protection of early embryogenesis and pluripotent stem cells against genetic parasites through a primitive immune system | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $1,375,266 | March 23, 2020 | February 28, 2025 | ZWAKA, THOMAS P. | reporter.nih.gov |
| Molecular mechanisms and genetic drivers of reciprocal genomic disorders | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $1,364,240 | September 15, 2018 | June 30, 2024 | TALKOWSKI, MICHAEL E | reporter.nih.gov |
| Immunomyoblasts in muscle regeneration | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,336,330 | May 10, 2021 | April 30, 2024 | KUANG, SHIHUAN | reporter.nih.gov |
| Epigenetic control of muscle stem cell function by PASK-Wdr5 signaling | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $1,322,588 | February 25, 2020 | November 30, 2025 | KIKANI, CHINTAN K | reporter.nih.gov |
| Functional genetics of tissue factor in bleeding and thrombotic risk | NIH | Office of the Director, National Institutes of Health | 2021 to 2023 | $1,312,500 | September 16, 2019 | August 31, 2025 | SCHULMAN, SOL | reporter.nih.gov |
| Stromal cell therapy as a treatment against Gastrointestinal Acute Radiation Syndrome (GI-ARS) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,193,484 | March 9, 2018 | February 29, 2024 | GUHA, CHANDAN | reporter.nih.gov |
| Cellular and Molecular Mechanisms of FUS-related ALS/FTD | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,161,739 | April 15, 2013 | January 31, 2025 | PANDEY, UDAI B | reporter.nih.gov |
| CD4 T cell stemness and inflammatory bowel disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,157,862 | September 1, 2020 | May 31, 2025 | HARRINGTON, LAURIE ELLEN | reporter.nih.gov |
| Mitochondria and TFAM in Osteoblast Biology | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2024 | $1,147,343 | July 15, 2019 | November 30, 2024 | SCHIPANI, ERNESTINA | reporter.nih.gov |
| R01 Renewal: Collaboration of chromatin remodeling and signaling pathways in pluripotency | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,119,364 | July 10, 2015 | July 31, 2024 | SRIDHARAN, RUPA | reporter.nih.gov |
| Using human iPSC derived microglia and chimeric models to examine the role of PLCG2 in Alzheimers disease | NIH | National Institute on Aging | 2021 to 2022 | $1,117,111 | September 30, 2018 | May 31, 2024 | DAVTYAN, HAYK | reporter.nih.gov |
| Signal Integration During Eye Formation | NIH | National Eye Institute | 2021 to 2023 | $1,077,805 | September 1, 2020 | August 31, 2025 | BROWN, NADEAN L | reporter.nih.gov |
| HIF-2alpha, a Novel Regulator of Osteoblastogenesis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,057,667 | January 11, 2019 | December 31, 2023 | SCHIPANI, ERNESTINA | reporter.nih.gov |
| Function of MLL in transcription regulation | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,052,562 | April 1, 2009 | April 30, 2025 | DOU, YALI | reporter.nih.gov |
| Targeting PTEN to ameliorate muscular dystrophy in a mouse model | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2024 | $989,224 | January 27, 2022 | December 31, 2024 | KUANG, SHIHUAN | reporter.nih.gov |
| Transplantation of Testis Stem Cells in Large Animals | NIH | Office of the Director, National Institutes of Health | 2021 to 2024 | $956,232 | September 1, 2013 | February 28, 2026 | DOBRINSKI, INA | reporter.nih.gov |
| Explore the APOE e4-mediated p53 activation in Alzheimer's Disease | NIH | Office of the Director, National Institutes of Health | 2021 to 2022 | $928,125 | February 1, 2019 | January 31, 2024 | ZHAO, RUI | reporter.nih.gov |
| Development of Pharmacological Treatment of Osteochondromas | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $905,493 | February 1, 2019 | January 31, 2025 | ENOMOTO-IWAMOTO, MOTOMI | reporter.nih.gov |
| Do we need Y chromosome for successful reproduction? | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $886,145 | August 25, 2012 | March 31, 2024 | WARD, MONIKA A | reporter.nih.gov |
| microRNA therapies for advanced brain tumors | NIH | National Cancer Institute | 2022 to 2024 | $828,287 | April 1, 2020 | December 31, 2025 | BHERE, DEEPAK | reporter.nih.gov |
| Diversity Supplement -- Vertebrate Photoreceptor Development and Regeneration | NIH | National Eye Institute | 2021 to 2022 | $817,376 | August 1, 2012 | July 31, 2024 | MORRIS, ANN C | reporter.nih.gov |
| Biorepository of iPSC lines from diverse rat strains for regenerative medicine research | NIH | Office of the Director, National Institutes of Health | 2021 | $801,204 | September 2, 2018 | May 31, 2023 | KIM, KWANG-SOO | reporter.nih.gov |
| Tetraspanin CD82 in muscle satellite cells quiescence and differentiation | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $763,224 | June 12, 2017 | February 29, 2024 | GUSSONI, EMANUELA | reporter.nih.gov |
| Trap+ Mononuclear Cells in Periosteal Bone Formation | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $758,817 | April 14, 2017 | February 28, 2023 | CAO, XU | reporter.nih.gov |
| Thyroid Follicular Cell Signaling and Development in Humans | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $727,494 | December 1, 2015 | April 30, 2023 | HOLLENBERG, ANTHONY N | reporter.nih.gov |
| Dissecting and reconstructing the molecular roadmaps of cellular reprogramming to iPSCs in single-cell resolution | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $721,218 | January 1, 2021 | December 31, 2023 | SHU, JIAN | reporter.nih.gov |
| Myonuclear homeostasis in craniofacial muscles | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $719,924 | August 1, 2017 | July 31, 2023 | CHOO, HYOJUNG | reporter.nih.gov |
| Microengineered scaffolds carrying patient-specific cells and growth factors for treatment of volumetric muscle loss | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $719,655 | November 1, 2019 | August 31, 2024 | TAMAYOL, ALI | reporter.nih.gov |
| H3.3-mediated epigenetic regulation of developmental bivalent genes for reprogramming and differentiation | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $711,900 | August 1, 2018 | May 31, 2025 | WEN, DUANCHENG | reporter.nih.gov |
| Application of a novel dCasNano-based Epigenetic Editing to Treat Rett Syndrome | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $698,459 | September 15, 2024 | February 28, 2026 | TSAI, YI-TING | reporter.nih.gov |
| CYLD in Synapse Pruning and Pathogenesis of FTD | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $682,211 | August 1, 2021 | July 31, 2023 | YAO, WEI-DONG | reporter.nih.gov |
| Epigenetic barriers to trophoblast differentiation from pluripotent stem cells | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $638,584 | December 2, 2017 | February 28, 2023 | FAZZIO, THOMAS G | reporter.nih.gov |
| Chromatin remodeling and gene expression during preimplantation development | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $638,518 | September 1, 2018 | May 31, 2024 | ROSS, PABLO JUAN | reporter.nih.gov |
| Transcriptional regulatory networks govering placental development. | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $597,887 | August 24, 2018 | May 31, 2024 | TUTEJA, GEETU | reporter.nih.gov |
| Role of Mitochondrial Metabolism in Regulating Species-Specific Developmental Rates | NIH | National Institute of General Medical Sciences | 2024 | $578,254 | September 1, 2024 | June 30, 2025 | DIAZ CUADROS, MARGARETE | reporter.nih.gov |
| White Matter Restoration in Vascular Cognitive Impairment and dementia | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $561,842 | September 15, 2020 | March 31, 2026 | CAO, GUODONG | reporter.nih.gov |
| Role of newly discovered SLFN14 in megakaryopoiesis and platelet development | NIH | National Heart, Lung, and Blood Institute | 2021 | $544,286 | May 5, 2020 | August 1, 2022 | PISAREV, ANDREY | reporter.nih.gov |
| Kinetic Imaging Cytometer (KIC) for High Throughput Studies of Cellular Physiology | NIH | Office of the Director, National Institutes of Health | 2021 | $528,325 | April 26, 2021 | October 25, 2022 | MERCOLA, MARK | reporter.nih.gov |
| The Role of Interferon Regulatory Factor 5 in the Pathogenesis of SLE | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $519,976 | September 22, 2017 | August 31, 2024 | RIFKIN, IAN R | reporter.nih.gov |
| Decoding the Molecular Mechanisms Underlying Reprogramming to Functional Hepatic and Intestinal Cell Types | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 | $503,630 | September 15, 2017 | November 3, 2024 | MORRIS, SAMANTHA ANNETTE | reporter.nih.gov |
| Regulation of Tendon Repair with Stem Cell-Derived Extracellular Vesicles | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 | $501,450 | September 18, 2023 | August 31, 2025 | SHEN, HUA | reporter.nih.gov |
| Innovative Approaches to Treat Duchenne Muscular Dystrophy Using iPSC-Derived Muscle Progenitors | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $499,954 | April 1, 2016 | March 31, 2023 | TANG, YAO LIANG | reporter.nih.gov |
| Genetic variation impacting the airway smooth muscle in children with asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $497,918 | September 1, 2017 | November 30, 2022 | ECKALBAR, WALTER | reporter.nih.gov |
| The impact of age-related changes in osteoclast function on the skeleton (R01) | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $495,592 | June 15, 2021 | December 17, 2021 | WEIVODA, MEGAN M | reporter.nih.gov |
| Frontiers in Stem Cells and Regeneration Course | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2024 | $478,320 | May 12, 2014 | April 30, 2025 | HYMAN, LINDA E | reporter.nih.gov |
| Neurogenic potential of murine Müller glia following retinal injury and conditional inactivation of p27Kip1 | NIH | National Eye Institute | 2022 to 2023 | $475,750 | January 1, 2022 | December 31, 2024 | LEVINE, EDWARD M | reporter.nih.gov |
| Genetic regulation of the cartilage callus during large-scale bone repair | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $470,201 | September 15, 2016 | July 31, 2023 | MARIANI, FRANCESCA V | reporter.nih.gov |
| Understanding mechanism and improving efficiency of somatic cell nuclear transfer | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $469,823 | August 19, 2017 | May 31, 2023 | ZHANG, YI | reporter.nih.gov |
| Bat pluripotent stem cells as a novel experimental system | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $464,750 | August 14, 2023 | July 31, 2025 | ZWAKA, THOMAS P. | reporter.nih.gov |
| Utilizing Bioprinted Human Stem Cells for Molecular Screening via Multi-Material Strategies | NIH | National Institute of Biomedical Imaging and Bioengineering | 2024 | $460,500 | September 18, 2024 | September 16, 2027 | SUH, WON HYUK | reporter.nih.gov |
| Mechanisms of gene regulation mediated by human-specific SVA transposons | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $455,000 | July 1, 2020 | August 31, 2022 | TRIZZINO, MARCO | reporter.nih.gov |
| Functions of parkin in Parkinson’s disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $450,326 | September 1, 2018 | March 31, 2023 | FENG, JIAN | reporter.nih.gov |
| Deciphering the tumor suppressive functions of macroH2A | NIH | National Cancer Institute | 2021 | $448,328 | June 16, 2017 | May 31, 2023 | BERNSTEIN, EMILY | reporter.nih.gov |
| The role of efferocytic macrophages in bone formation | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $445,583 | September 20, 2021 | August 31, 2023 | MCCAULEY, LAURIE K. | reporter.nih.gov |
| An inorganic polyphosphate-impregnated synthetic periosteum drives allograft osteointegration | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2023 | $437,828 | June 4, 2022 | April 30, 2025 | SCHOENECKER, JONATHAN | reporter.nih.gov |
| The Role of RBM20 Sequence and Expression in Dilated Cardiomyopathies | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $434,982 | August 5, 2019 | July 31, 2024 | PARIKH, VICTORIA | reporter.nih.gov |
| Discovery of aberrant enhancer activities during gut development that underlie genetic predisposition to pediatric Crohn's disease | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $431,750 | September 24, 2021 | August 31, 2024 | SETHUPATHY, PRAVEEN | reporter.nih.gov |
| Factors Regulating Development of Appendicular Skeletal Progenitors | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $429,000 | February 11, 2015 | August 31, 2024 | DUESTER, GREGG L | reporter.nih.gov |
| Establishment of xenopus stem cell lines | NIH | Office of the Director, National Institutes of Health | 2023 to 2024 | $423,500 | September 1, 2023 | August 31, 2025 | GOUIGNARD, NADEGE | reporter.nih.gov |
| Conditional mouse models with dominant negative Osteogenesis Imperfecta | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2024 | $422,499 | March 1, 2023 | April 30, 2025 | WARMAN, MATTHEW L | reporter.nih.gov |
| Pathway discovery for ubiquilin-associated ALS/Dementia | NIH | National Institute on Aging | 2021 | $421,841 | March 1, 2021 | February 29, 2024 | KIM, SANG HWA | reporter.nih.gov |
| Engineering the Organizer | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $415,206 | July 15, 2021 | June 30, 2024 | DAVIDSON, LANCE A. | reporter.nih.gov |
| The skin of naked mole rats as a model for scar-free wound healing | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 | $406,225 | September 1, 2020 | August 31, 2025 | BOTCHKAREV, VLADIMIR A | reporter.nih.gov |
| Unbiased mapping of skeletal stem cell function at single cell resolution in homeostasis and injury. | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2024 | $404,597 | March 1, 2023 | February 28, 2026 | LEUCHT, PHILIPP | reporter.nih.gov |
| Defining the human adventitial stem cell niche | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2023 | $404,048 | August 18, 2022 | July 31, 2024 | JAMES, AARON W | reporter.nih.gov |
| A lung cancer vaccine based on exosomes of induced pluripotent stem cells | NIH | National Cancer Institute | 2023 | $402,401 | September 20, 2023 | August 31, 2025 | LI, CHI | reporter.nih.gov |
| Title: In Vitro Analysis of the Effects of Acute and Chronic Phthalate Exposures on Leydig Cell Testosterone Production, and the Molecular Mechanisms Involved | NIH | National Institute of Environmental Health Sciences | 2023 | $401,895 | April 1, 2023 | August 31, 2026 | TRAORE, KASSIM | reporter.nih.gov |
| Mechanisms underlying DNA double strand break response in Alzheimer?s disease and frontal temporal dementia | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $401,374 | September 15, 2017 | June 30, 2023 | TSAI, LI-HUEI | reporter.nih.gov |
| Circadian regulation of NAMPT in the heart | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $400,000 | August 22, 2022 | July 31, 2025 | ZHANG, LILEI | reporter.nih.gov |
| Role of GI OSTERIX in Gut and Bone Biology | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $394,064 | September 28, 2021 | August 31, 2025 | YANG, WENTIAN | reporter.nih.gov |
| Fat and synovial tissue remodeling in joint osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $393,250 | September 22, 2021 | August 31, 2024 | QIN, LING | reporter.nih.gov |
| Layer-by-Layer Nano Matrix for Growth Plate Regeneration | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2023 | $392,787 | June 17, 2022 | May 31, 2025 | CHEN, YUPENG | reporter.nih.gov |
| Dynamic heterogeneity of nucleus pulposus cells from development to degeneration | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $391,353 | May 5, 2021 | April 30, 2024 | SMITH, LACHLAN JAMES | reporter.nih.gov |
| Gene Therapy for MPS IV A in a Novel Porcine Model of the Disease | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 | $384,999 | September 18, 2024 | August 31, 2025 | CAMPBELL, JARRYD MATTHEW | reporter.nih.gov |
| Oxysterols in SLOS Neurodevelopment: Pathological Role and Therapy | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $383,278 | July 25, 2017 | June 30, 2023 | XU, LIBIN | reporter.nih.gov |
| Blastema-independent Mechanism for Regeneration in Salamanders | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2023 | $379,940 | February 1, 2022 | December 31, 2025 | PLIKUS, MAKSIM V | reporter.nih.gov |
| Ex vivo expansion of skeletal muscle satellite cells | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2023 | $378,232 | February 10, 2022 | December 31, 2024 | CORNELISON, DAWN D | reporter.nih.gov |
| N6-Methyladenosine RNA Methylation in Myogenesis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $377,520 | September 22, 2021 | August 31, 2024 | DEY, BIJAN K | reporter.nih.gov |
| Synthetic Chronogenetic Gene Circuits for Circadian Cell Therapies | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 | $376,310 | September 20, 2023 | September 19, 2025 | GUILAK, FARSHID | reporter.nih.gov |
| SMART stem cells that autonomously down-modulate TFG-β signaling for Articular Cartilage Repair | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2023 | $376,018 | March 15, 2022 | January 31, 2024 | HUARD, JOHNNY | reporter.nih.gov |
| Systemic delivery of muscle stem cell for muscle disease therapy | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2023 | $375,100 | May 1, 2022 | April 30, 2024 | ASAKURA, ATSUSHI | reporter.nih.gov |
| Cellular Mechanisms of Age-Associated Cortical Bone Remodeling | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 | $375,100 | September 20, 2024 | August 31, 2026 | BRADLEY, ELIZABETH W | reporter.nih.gov |
| Programmed cells for targeted articular regenerative medicine | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $374,188 | July 1, 2021 | May 31, 2024 | BRUNGER, JONATHAN MATTHEW | reporter.nih.gov |
| Targeting vascular endothelium for muscular dystrophy therapy | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $373,065 | April 1, 2021 | March 31, 2024 | ASAKURA, ATSUSHI | reporter.nih.gov |
| Improving tendon-to-bone repair with hedgehog signaling therapeutics | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $371,181 | July 15, 2021 | May 31, 2024 | DYMENT, NATHANIEL A. | reporter.nih.gov |
| Modeling to design optimized estrogen-specific muscle regeneration treatment | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2023 | $368,958 | February 1, 2022 | December 31, 2024 | BLEMKER, SILVIA SALINAS | reporter.nih.gov |
| Mechanistic and Translational Investigations of HSPB8-associated dominant rimmed vacuolar myopathy | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 | $368,764 | September 20, 2024 | August 31, 2026 | KIMONIS, VIRGINIA EUNICE | reporter.nih.gov |
| Preventive and Therapeutic Effects of Bone Marrow Stem Cell-Derived Exosomes on Spine Dural Fibrosis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2023 | $367,342 | May 10, 2022 | April 30, 2026 | SEOL, DONG RIM | reporter.nih.gov |
| Introducing a Chondroinductive Peptide | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $366,350 | September 24, 2021 | August 31, 2024 | DETAMORE, MICHAEL S. | reporter.nih.gov |
| Extracellular vesicles produced by CRISPR-activated MSCs: A potential therapy for degenerative disc disease | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2024 | $364,608 | September 1, 2023 | July 31, 2026 | WUERTZ-KOZAK, KARIN | reporter.nih.gov |
| Generation and Validation of Disease Models for Port-Wine Birthmarks | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2024 | $355,663 | August 1, 2023 | July 31, 2025 | TAN, WENBIN | reporter.nih.gov |
| Autonomous RUNX2 suppression in genetically modified stem cell-derived chondrocytes as a disease modifying therapeutic for PTOA | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2024 | $355,513 | March 3, 2023 | January 31, 2026 | COLEMAN, RHIMA | reporter.nih.gov |
| Enhance myogenic transdifferentiation efficiency using engineering approaches | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2024 | $354,166 | May 1, 2023 | April 30, 2026 | SHEN, WEI | reporter.nih.gov |
| Targeting Dystroglycanopathies using Pluripotent-derived Myogenic Progenitors | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $353,874 | May 10, 2017 | March 31, 2022 | PERLINGEIRO, RITA C. R. | reporter.nih.gov |
| Smart, integrated well-plates for ultra-high-throughput screening of excitation-contraction coupling in tissues | NIH | National Institute of General Medical Sciences | 2021 | $350,000 | September 14, 2021 | August 31, 2023 | PUSHKARSKY, IVAN | reporter.nih.gov |
| Investigating the pro-aging role of B2M and MHC molecules on regenerative and cognitive function in the brain | NIH | National Institute on Aging | 2021 | $324,925 | March 1, 2017 | February 28, 2022 | VILLEDA, SAUL A | reporter.nih.gov |
| Transcriptional and Epigenetic Control of Pluripotency and Development by Zfp281 | NIH | National Institute of General Medical Sciences | 2021 | $324,000 | August 6, 2018 | April 30, 2023 | WANG, JIANLONG | reporter.nih.gov |
| Tendon Tissue Engineering Informed by Lysyl Oxidase Regulation of Embryonic Tendon Mechanical Properties | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $319,996 | September 21, 2017 | August 31, 2024 | KUO, CATHERINE K. | reporter.nih.gov |
| Differentiation and Integration of Trisomy 21 iPSCs in an Animal Model | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $319,259 | August 1, 2017 | April 30, 2023 | TIAN, LIN | reporter.nih.gov |
| Engineered gamma delta T cells for systemic correction of dystrophic epidermolysis bullosa | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 | $313,370 | August 22, 2024 | July 31, 2025 | SHIRKEY-SON, NICOLE J. | reporter.nih.gov |
| Cell-based Gene Therapy for MPS IVA | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 | $306,872 | August 1, 2024 | July 31, 2026 | MOUNZIH, KHALID | reporter.nih.gov |
| A BioAdhesive to Localize and Direct Stem Cells to Treat Damaged Cartilage | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $299,574 | September 20, 2021 | February 28, 2023 | TSINMAN, ANTONINA | reporter.nih.gov |
| A comparative analysis of endogenous vs. pluripotent stem cell-derived cardiomyocytes for heart regeneration | NIH | National Institute on Aging | 2021 to 2022 | $293,194 | September 30, 2021 | January 16, 2023 | ARDEHALI, REZA | reporter.nih.gov |
| Identifying human-specific neural progenitors and their role in neurodevelopment | NIH | National Institute of Mental Health | 2023 to 2024 | $272,484 | May 1, 2023 | April 30, 2025 | JANG, SUMIN | reporter.nih.gov |
| Function of reactive astrocytes in aging and neurodegenerative disease | NIH | National Institute on Aging | 2021 to 2023 | $259,273 | September 1, 2020 | January 8, 2024 | BATTAGLIA, RACHEL | reporter.nih.gov |
| Mechanisms of Skeletal Morphogenesis During Digit Tip Regeneration | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2023 | $257,036 | July 1, 2022 | August 31, 2023 | QU, FEINI | reporter.nih.gov |
| Development of Safe in Utero Gene Editing Technology in Mice | NIH | National Center for Advancing Translational Sciences | 2021 | $256,580 | April 19, 2021 | April 18, 2023 | RABUKA, DAVID | reporter.nih.gov |
| Small Molecules Promote Tendon Regeneration by Targeting Endogenous Stem Cells | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $252,131 | September 5, 2021 | August 31, 2022 | CHEN, MO | reporter.nih.gov |
| High resolution characterization of epigenetic dynamics in gastrointestinal cell plasticity | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2024 | $242,550 | February 1, 2023 | January 31, 2025 | JADHAV, UNMESH | reporter.nih.gov |
| Investigation of the neuroimmune axis in retinal regeneration. | NIH | National Eye Institute | 2022 to 2023 | $240,216 | February 1, 2022 | September 30, 2023 | TODD, LEVI J. | reporter.nih.gov |
| Regulating cell-cell interactions to improve donor retinal ganglion cell integration | NIH | National Eye Institute | 2022 to 2024 | $221,530 | February 1, 2022 | January 31, 2025 | SOUCY, JONATHAN R | reporter.nih.gov |
| A Metabolic Strategy Utilizing a Zein Scaffold for Bone Repair | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $213,424 | May 1, 2021 | April 30, 2023 | ARINZEH, TREENA LYNNE | reporter.nih.gov |
| Elucidation of mitochondrial mechanisms critical to mediating PFAS neurotoxicity | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $209,594 | September 1, 2021 | March 31, 2023 | SAMMI, SHREESH RAJ | reporter.nih.gov |
| Brain organoid modeling of Gaucher disease for identification of pathogenic pathways and therapy development | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $198,750 | September 8, 2020 | July 31, 2022 | SUN, YING | reporter.nih.gov |
| Analysis of environmentally-sensitive epigenetic machinery during osteogenic differentiation | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $196,332 | December 15, 2020 | August 31, 2022 | SPARKS, NICOLE RENEE | reporter.nih.gov |
| The Role of Autophagy in Intestinal Regeneration | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $182,121 | May 1, 2021 | November 30, 2024 | DEANS-FIELDER, KALI KRISTINNA | reporter.nih.gov |
| Modulation of CD8+ T cell differentiation and anti-tumor immunity by metabolic manipulation | NIH | National Center for Advancing Translational Sciences | 2024 | $169,500 | September 1, 2024 | August 31, 2026 | MARKOWITZ, GEOFFREY JOSEPH | reporter.nih.gov |
| Biomineralization potential of inorganic polymer for bone tissue regenerative engineering | NIH | National Center for Advancing Translational Sciences | 2023 | $141,478 | September 6, 2023 | August 31, 2025 | AKONO, ANGE-THERESE | reporter.nih.gov |
| Patterns and Mechanisms Underlying Somatic Mutations Across Long-Lived Bats | NIH | National Institute on Aging | 2024 | $138,564 | August 1, 2024 | July 31, 2025 | VAZQUEZ, JUAN MANUEL | reporter.nih.gov |
| next-generation sequencing approaches to identify genotype-phenotype relationships during miRNA tuning of neural crest osteogenesis | NIH | National Institute of Dental & Craniofacial Research | 2023 | $126,958 | May 1, 2023 | April 30, 2025 | ZUR NIEDEN, NICOLE ISOLDE | reporter.nih.gov |
| Modifying regulators of heterochromatin to improve reprogramming to functional hepatocytes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $123,342 | August 1, 2018 | September 30, 2022 | MCCARTHY, RYAN LEHMAN | reporter.nih.gov |
| Expanding retinal regenerative potential through chromatin biology in single cells | NIH | National Eye Institute | 2022 to 2023 | $122,919 | July 1, 2022 | June 30, 2025 | TRESENRIDER, AMY | reporter.nih.gov |
| WISP3 and Progressive Pseudorheumatoid Arthropathy of Childhood | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 | $122,284 | September 16, 2024 | August 31, 2025 | CRAFT, APRIL MARIE | reporter.nih.gov |
| Functional Genetics Approaches to Investigate Human Evolution | NIH | National Human Genome Research Institute | 2021 to 2023 | $113,718 | August 11, 2021 | December 31, 2023 | FAIR, TYLER | reporter.nih.gov |
| Reduction of the Olfactory Bulb and Reuse of its Inhibitory Neurons in the Primate Cerebrum | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $109,944 | September 1, 2021 | September 2, 2023 | SCHMITZ, MATTHEW T | reporter.nih.gov |
| Cardiac Calsequestrin (Casq2) function in excitation-contraction coupling and cardiac arrhythmias | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $100,046 | February 1, 2019 | January 31, 2023 | WLEKLINSKI, MATTHEW J | reporter.nih.gov |
| Mapping p53 dynamics to cell-fate outcomes in reprogramming and oncogenesis | NIH | National Cancer Institute | 2023 to 2024 | $98,168 | August 11, 2023 | July 31, 2025 | BEITZ, ADAM MATTHEW | reporter.nih.gov |
| The Role of Fat in Osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2023 | $97,609 | April 24, 2022 | April 30, 2023 | COLLINS, KELSEY HELEN-MARIE | reporter.nih.gov |
| Deciphering the role of mitochondrial/autophagy dysfunction in regulating inflammatory processes during AMD pathogenesis | NIH | National Eye Institute | 2024 | $92,707 | September 1, 2023 | August 31, 2025 | GHOSH, SAYAN | reporter.nih.gov |
| Determining the Mechanism of Transformation for Rhabdomyosarcoma | NIH | National Cancer Institute | 2021 to 2022 | $84,788 | January 1, 2021 | December 31, 2022 | SEARCY, MADELINE BUSH | reporter.nih.gov |
| Investigating Mitogenic Mechanism and Therapeutic Efficacy of Adenosine Deaminase Knockout in Human and Murine Cardiomyocytes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $83,960 | September 30, 2022 | September 29, 2024 | DELUCA, SOPHIA BUNNELL | reporter.nih.gov |
| Molecular and cellular mechanisms of heterotopic ossification | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 | $76,453 | August 1, 2010 | July 31, 2022 | YU, PAUL B | reporter.nih.gov |
| Local modulation of S1P receptor signaling with nanofibrous hyaluronic acid scaffolds as a regenerative immunotherapy following critical volumetric muscle loss injury | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2023 | $73,359 | September 1, 2022 | December 31, 2023 | HYMEL, LAUREN ALEXANDRA | reporter.nih.gov |
| Comparative Single Cell Profiling of Retinal Development | NIH | National Eye Institute | 2021 to 2022 | $68,454 | May 3, 2021 | June 30, 2022 | WEIR, KURT L | reporter.nih.gov |
| Dissecting the roles of Polycomb repressive complex 2 accessory subunits during early developmental transitions | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $51,335 | July 1, 2020 | December 22, 2022 | PETRACOVICI, ANA | reporter.nih.gov |
| Biasing cell-fate specification through identification and perturbation of mechanisms regulating noise in NANOG expression. | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $51,036 | March 1, 2018 | February 28, 2022 | DESAI, RAVI | reporter.nih.gov |
| Understanding the chromatin architectural landscape of retinal development at the single-cell level | NIH | National Eye Institute | 2024 | $48,974 | August 15, 2024 | May 31, 2025 | TRINH, VICKIE | reporter.nih.gov |
| 2024 Epithelial Stem Cells and Niches Gordon Research Conference and Seminar | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 | $41,520 | May 1, 2024 | April 30, 2025 | KLEIN, OPHIR D | reporter.nih.gov |
| Genetic dissection of cis-acting elements controlling DNA replication timing and genome architecture | NIH | National Institute on Aging | 2021 | $40,640 | September 1, 2020 | August 31, 2022 | TURNER, JESSE LLOYD | reporter.nih.gov |
| Diversity in a Dish: Pluripotent Stem Cells in Genetic Analysis and Disease Modeling | NIH | Office of the Director, National Institutes of Health | 2023 to 2024 | $40,000 | March 1, 2023 | February 28, 2025 | BAKER, CHRISTOPHER LEE | reporter.nih.gov |
| PRODUCING PIG INDUCED PLURIPOTENT STEM CELLS FOR CARDIOVASCULAR TISSUE ENGINEERING | NIH | National Heart, Lung, and Blood Institute | 2021 | $35,320 | September 1, 2019 | August 31, 2022 | BATTY, LUKE DANIEL | reporter.nih.gov |
| Bioprinting A Physiologically Aligned, Thick Cardiac Tissue for Regenerative Medicine | NIH | National Heart, Lung, and Blood Institute | 2021 | $34,938 | September 1, 2019 | August 31, 2022 | AHRENS, JOHN | reporter.nih.gov |
| Investigating the Mechanism of Hair Follicle Placode Induction : A novel approach to understanding establishment of the periodic pattern | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 | $32,974 | December 1, 2024 | November 30, 2029 | PHILLIPS, BROOKE K | reporter.nih.gov |
| Skeletal Muscle Stem Cells in Development, Regeneration, and Adaptations | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 | $31,750 | April 1, 2024 | March 31, 2025 | MILLAY, DOUGLAS PAUL | reporter.nih.gov |
| Skeletal Muscle: Development, Regeneration and Disease | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $20,000 | May 6, 2021 | April 30, 2022 | CHEN, ELIZABETH H | reporter.nih.gov |
| Organoids as Models of Development and Disease, and their Impact on Drug Discovery | NIH | National Center for Advancing Translational Sciences | 2023 | $19,800 | January 1, 2023 | December 31, 2023 | SHEPPARD, TERRY L. | reporter.nih.gov |
| 2025 Myogenesis Gordon Research Conference and Gordon Research Seminar | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 | $18,000 | September 20, 2024 | September 19, 2025 | CORNELISON, DAWN D | reporter.nih.gov |
| Coupling of muscle blind-dependent RNA processing to the circadian clock in neuronal homeostasis and sleep | NIH | National Heart, Lung, and Blood Institute | 2021 | $16,796 | March 1, 2019 | May 7, 2021 | PERELIS, MARK | reporter.nih.gov |
| 2020 Neural Development Gordon Research Conference and Gordon Research Seminar | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $15,000 | September 24, 2021 | August 31, 2022 | DESPLAN, CLAUDE | reporter.nih.gov |
| A Translational Bioreactor for the Construction of Off-the-Shelf, Patient-Specific Heart Tissue for the Permanent Correction of Congenital Heart Defects | NIH | National Heart, Lung, and Blood Institute | 2021 | $10,937 | September 1, 2020 | December 31, 2021 | JARRELL, DILLON K | reporter.nih.gov |
| Cell and Gene Therapy for Neurodevelopmental Disorders Conference | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $10,000 | September 15, 2021 | August 31, 2022 | NOLTA, JAN A. | reporter.nih.gov |
| Investigating the roles of active DNA demethylation pathways in epigenetic reprogramming | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $2,100 | July 1, 2019 | June 30, 2022 | CALDWELL, BLAKE ALEXANDER | reporter.nih.gov |
Organizations
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2024 | 53 | $16,253,341 | 0 | $0 |
| 2023 | 78 | $24,450,956 | 0 | $0 |
| 2022 | 93 | $33,489,405 | 0 | $0 |
| 2021 | 112 | $44,268,738 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.